South Korea ensures the quality of active pharmaceutical ingredients (APIs) through stringent regulations set by the Ministry of Food and Drug Safety (MFDS). Manufacturers must comply with Good Manufacturing Practices (GMP), undergo regular inspections, and submit detailed quality control data. APIs are... Read More
The drug registration in South Korea process aligns closely with global standards, particularly those of the U.S. FDA and European Medicines Agency (EMA). The Ministry of Food and Drug Safety (MFDS) follows international guidelines on safety, efficacy, and quality. Additionally, South Korea... Read More
Importers must submit detailed documentation on the drug’s quality, safety, and efficacy. The MFDS conducts inspections, testing, and adherence to international standards like Good Manufacturing Practices (GMP) before granting import approval. Read More
The Korean drug approval process ensures that multinational companies meet local safety, efficacy, and quality standards before marketing their drugs in South Korea. Companies must submit clinical trial data, comply with regulatory requirements, and gain approval from agencies like the Ministry of... Read More
Orphan drugs are registered through a specialized process managed by the Ministry of Food and Drug Safety (MFDS) in South Korea. They receive expedited review, reduced clinical trial requirements, and financial incentives. These measures encourage the development and approval of treatments for... Read More
Herbal medicines in South Korea are registered through the Ministry of Food and Drug Safety (MFDS). The process involves submitting evidence of safety, efficacy, and quality, often including traditional use data and scientific research. Manufacturers must meet Good Manufacturing Practice (GMP) standards,... Read More
Preclinical data for drug registration in South Korea must comply with guidelines set by the Ministry of Food and Drug Safety (MFDS). This includes safety and efficacy data from laboratory and animal studies, conducted under Good Laboratory Practice (GLP) standards. The data... Read More
Controlled substances in South Korea are strictly regulated by the Ministry of Food and Drug Safety (MFDS) under the Narcotics Control Act. Companies must obtain special permits, follow strict handling, storage, and distribution guidelines, and provide detailed safety and abuse potential data... Read More
In South Korea, drug stability tests for registration follow Ministry of Food and Drug Safety (MFDS) guidelines. These tests assess a drug’s quality, potency, and safety over time under various environmental conditions, including temperature, humidity, and light. Stability data supports shelf-life determination,... Read More
The approval process for new drug delivery systems in South Korea involves submitting detailed data on safety, efficacy, and functionality to the Ministry of Food and Drug Safety (MFDS). Preclinical and clinical trial data must demonstrate the system’s performance, stability, and patient... Read More